This inventor holds 1 USPTO granted patent. Top assignee: Licentia, Ltd.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Dimitri Poteriaev: Innovator in Neuronal and Endocrine Research
Introduction
Dimitri Poteriaev is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of biotechnology, particularly in the area of neuronal disorders and endocrine tumors. His work focuses on the development of compounds related to GFRα4, which have important implications for medical research and treatment.
Latest Patents
Dimitri holds a patent for "Compounds related to or derived from GFRα4 and their use." This invention discloses purified and isolated nucleic acid sequences encoding polypeptides that are substantially similar to splicing forms of mammalian GFRα4. The patent includes preferred sequences comprising cDNAs and is related to substances capable of specifically recognizing these polypeptides, including antibodies and receptors. The active compounds of this invention are useful for producing cell lines and transgenic non-human animals, as well as for diagnosing and treating neuronal disorders and endocrine tumors.
Career Highlights
Dimitri Poteriaev is associated with Licentia, Ltd., where he continues to advance his research and innovations. His work has the potential to significantly impact the understanding and treatment of various diseases related to neuronal signaling and endocrine functions.
Collaborations
Dimitri has collaborated with notable researchers in his field, including Mart Saarma and Tönis Timmusk. These collaborations have likely contributed to the depth and breadth of his research endeavors.
Conclusion
Dimitri Poteriaev is a prominent figure in the field of biotechnology, with a focus on GFRα4-related compounds. His innovative work holds promise for advancing medical treatments for neuronal and endocrine disorders.